Literature DB >> 3084022

Toxoplasmosis in cardiac transplantation.

M Hakim, D Esmore, J Wallwork, T A English, T Wreghitt.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3084022      PMCID： PMC1340043          DOI： 10.1136/bmj.292.6528.1108

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Probable transmission of Toxoplasma gondii by organ transplantation.

Authors:  F W Ryning; R McLeod; J C Maddox; S Hunt; J S Remington
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 2.  Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

Authors:  B D Kahan
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

3.  Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera.

Authors:  A H Balfour; D G Fleck; H P Hughes; D Sharp
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

4.  Significance of donor transmitted disease in cardiac transplantation.

Authors:  M Hakim; T G Wreghitt; T A English; P G Stovin; R Cory-Pearce; J Wallwork
Journal:  J Heart Transplant       Date:  1985-05

5.  New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

Authors:  D G Mack; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191
  5 in total
  11 in total

1.  Self-limited Toxoplasma parasitemia after liver transplantation.

Authors:  S Kusne; J S Dummer; M Ho; T Whiteside; B S Rabin; L Makowka; C O Esquivel; T E Starzl
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

Review 2.  Antimicrobial strategies in the care of organ transplant recipients.

Authors:  R H Rubin; N E Tolkoff-Rubin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  Immunological response in experimentally reactivated toxoplasmosis in mice.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

4.  Problems with serological diagnosis of Toxoplasma gondii infections in heart transplant recipients.

Authors:  T G Wreghitt; J J Gray; A H Balfour
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

Review 5.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration.

Authors:  C H Spes; C E Angermann; H U Stempfle; K Wenke; K Theisen
Journal:  Clin Investig       Date:  1992-09

7.  Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation.

Authors:  M Anthuber; B M Kemkes; E Kreuzer; M Gokel; A Schuetz; C Kugler; F Sudhoff
Journal:  Tex Heart Inst J       Date:  1991

8.  Toxoplasmosis in heart and heart and lung transplant recipients.

Authors:  T G Wreghitt; M Hakim; J J Gray; A H Balfour; P G Stovin; S Stewart; J Scott; T A English; J Wallwork
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

Review 9.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

10.  Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients.

Authors:  J F Sluiters; A H Balk; C E Essed; B Mochtar; W Weimar; M L Simoons; E P Ijzerman
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.